27572131|t|Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon
27572131|a|Glucagon family of peptide hormones is a group of structurally related brain-gut peptides that exert their pleiotropic actions through interactions with unique members of class B1 G protein-coupled receptors (GPCRs). They are key regulators of hormonal homeostasis and are important drug targets for metabolic disorders such as type-2 diabetes mellitus (T2DM), obesity, and dysregulations of the nervous systems such as migraine, anxiety, depression, neurodegeneration, psychiatric disorders, and cardiovascular diseases. The current review aims to provide a detailed overview of the current understanding of the pharmacological actions and therapeutic advances of three members within this family including glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), and glucagon.
27572131	0	23	Pharmacological Actions	T038	C0007992
27572131	27	50	Glucagon-Like Peptide-1	T116	C0061355
27572131	52	82	Gastric Inhibitory Polypeptide	T116,T121,T125	C0017132
27572131	88	96	Glucagon	T116,T121,T125	C0017687
27572131	97	112	Glucagon family	T116,T121,T125	C0017687
27572131	116	132	peptide hormones	T116,T125	C0597192
27572131	168	186	brain-gut peptides	T116	C0030956
27572131	204	223	pleiotropic actions	T045	C2936488
27572131	232	244	interactions	T045	C0596610
27572131	250	276	unique members of class B1	T185	C0008902
27572131	277	304	G protein-coupled receptors	T116,T192	C0682972
27572131	306	311	GPCRs	T116,T192	C0682972
27572131	327	337	regulators	T077	C1704735
27572131	341	349	hormonal	T080	C0458083
27572131	350	361	homeostasis	T038	C0019868
27572131	380	392	drug targets	T074	C0085104
27572131	397	416	metabolic disorders	T047	C0025517
27572131	425	449	type-2 diabetes mellitus	T047	C0011860
27572131	451	455	T2DM	T047	C0011860
27572131	458	465	obesity	T047	C0028754
27572131	471	508	dysregulations of the nervous systems	T047	C0027765
27572131	517	525	migraine	T047	C0149931
27572131	527	534	anxiety	T048	C0003469
27572131	536	546	depression	T048	C0011570
27572131	548	565	neurodegeneration	T049	C0027746
27572131	567	588	psychiatric disorders	T048	C0004936
27572131	594	617	cardiovascular diseases	T047	C0007222
27572131	665	673	overview	T170	C0814812
27572131	710	733	pharmacological actions	T038	C0007992
27572131	738	758	therapeutic advances	T061	C0087111
27572131	805	828	glucagon-like peptide-1	T116	C0061355
27572131	830	835	GLP-1	T116	C0061355
27572131	838	868	gastric inhibitory polypeptide	T116,T121,T125	C0017132
27572131	870	873	GIP	T116,T121,T125	C0017132
27572131	880	888	glucagon	T116,T121,T125	C0017687